Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous cd34+ cells (2 trials)
Filgrastim (neupogen) (1 trial)
Infarction (Phase 2)
Myocardial Infarction (Phase 2)
Trials (3 total)
Trial APIs (2 total)